Results 161 to 170 of about 28,483 (297)

Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type of the Canadian Alteplase for Stroke Effectiveness Study Registry [PDF]

, 2007
Richard Libman, Thomas Kwiatkowski
openalex   +1 more source

Successful administration of alteplase in a venous thromboembolism crossing through a patent foramen ovale [PDF]

, 2009
Manuel Ruiz-Bailén, José Ángel Ramos-Cuadra, Juan Machado-Casas, Luis Rucabado-Aguilar   +3 more
openalex   +1 more source

The Use of Alteplase for the Resolution of an Intravesical Clot in a Neonate Receiving Extracorporeal Membrane Oxygenation

, 2001
Jose Luis Olarte, Mark L. Glover, Balagangadhar Totapally   +2 more
openalex   +1 more source

Is the Maximum Dose of 90 mg Alteplase Sufficient for Patients With Ischemic Stroke Weighing >100 kg? [PDF]

, 2011
Jennifer Diedler, Niaz Ahmed, Jörg Glahn, Martin Grond, Svetlana Lorenzano, M Brozman, M. Sýkora, Peter A. Ringleb   +7 more
openalex   +1 more source

Fibrinogen time course in acute ischemic stroke patients treated with intravenous thrombolysis with alteplase or tenecteplase. [PDF]

Eur Stroke J
Theodorou A, Psychogios K, Kargiotis O, Safouris A, Chondrogianni M, Bakola E, Melanis K, Fanouraki S, Frantzeskaki F, Polyzogopoulou E, Magoufis G, Themistocleous M, Palaiodimou L, Stefanou MI, Turc G, Alexandrov AV, Tsivgoulis G.   +16 more
europepmc   +1 more source

Pneumonie – Wie wirksam ist die Instillation von Alteplase? [PDF]

, 2013
Matthias Manych
openalex   +1 more source

Alteplase- and Tenecteplase-Related Errors and Risk Mitigation Strategies in the Treatment of Acute Ischemic Stroke: A Study of Event Reports From 52 Hospitals

Patient Safety
# Background Alteplase and tenecteplase are thrombolytic agents used to treat patients with acute ischemic stroke (AIS). Despite the convenient bolus dosing of tenecteplase, its off-label use for AIS creates new patient safety challenges that are ...
Myungsun Ro, Matthew A. Taylor, Rebecca Jones   +2 more
doaj   +1 more source

Dissolving porcine and human microthrombi by short exposure to microdoses of alteplase in an in vitro model of microvascular obstruction. [PDF]

Sci Rep
Milusev A, Rösch Y, Kuster Y, Wolint P, Ulmer J, Weisskopf M, Cesarovic N, Obrist D.   +7 more
europepmc   +1 more source

The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions

, 2003
Koji Sugimoto, Lawrence V. Hofmann, Mahmood K. Razavi, Stephen T. Kee, Daniel Y. Sze, Michael D. Dake, Charles P. Semba   +6 more
openalex   +1 more source

Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke

New England Journal of Medicine, 2018
B. Campbell, P. Mitchell, L. Churilov, N. Yassi, T. Kleinig, R. Dowling, B. Yan, Steven Bush, H. Dewey, V. Thijs, R. Scroop, M. Simpson, M. Brooks, H. Asadi, Teddy Y. Wu, D. Shah, T. Wijeratne, T. Ang, F. Miteff, C. Levi, E. Rodrigues, Henry Zhao, P. Salvaris, C. Garcia-Esperon, P. Bailey, H. Rice, L. de Villiers, H. Brown, K. Redmond, D. Leggett, J. Fink, W. Collecutt, A. Wong, C. Muller, A. Coulthard, K. Mitchell, J. Clouston, K. Mahady, D. Field, Henry Ma, T. Phan, W. Chong, R. Chandra, L. Slater, M. Krause, T. Harrington, K. Faulder, B. Steinfort, C. Bladin, G. Sharma, Patricia Desmond, M. Parsons, G. Donnan, Stephen M. Davis   +53 more
semanticscholar   +1 more source